In part 1 of this 2-part preview of AAPS PharmSci 360’s keynote on predictive drug development, Robert Holt, PhD, associate ...
The finalists for the 2026 CPHI Pharma Awards span15 categories including API development, digital transformation, ...
On August 31, 2026, Eli Lilly announced it has entered a definitive agreement to acquire Merida Biosciences, a biotechnology ...
Content on PharmTech.com this week showed that while AI is being utilized in drug discovery, manufacturing execution still lags behind. However, manufacturers are rethinking where and how they build ...
Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.
In August 2026, Heidi Overton was nominated for FDA commission, and a wave of oncology and neuro drugs were approved. In ...
David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.
The FDA cleared four notable therapies within the same week in late August, spanning infectious disease, cardiometabolic care ...
In December 2025, FDA announced that it was deploying agentic AI capabilities across the agency. FDA defined these systems as ...
FDA approves Rasonque (daraxonrasib), the first broad RAS-targeted therapy for metastatic pancreatic cancer, validating RAS ...
This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results